AKBA Competitors & Alternatives

Compare Akebia Ther with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

AKBA

Main Stock
$1.43
Tradestie Score
53
Market Cap
$710.59M
Revenue Growth
-0.1%
Analyst Upside
+193.7%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.78
$1.02B - 63 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.24
$711.32M - 53 Compare
ESPR Esperion Therapeutics, Inc.
$3.19
$584.71M - 54 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.33
$543.32M - 60 Compare
ALDX Aldeyra Therapeutics, Inc.
$2.30
$314.64M - 62 Compare
ABEO Abeona Therapeutics Inc. Common Stock
$7.12
$270.75M 7.2 66 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.67
$237.15M 7.2 64 Compare
BIOA BioAge Labs, Inc. Common Stock
$24.89
$212.23M - 57 Compare
KPTI Karyopharm Therapeutics Inc.
$10.20
$53.85M - 59 Compare
KYNB KYNB
$7.32
- - 62 Compare

Data updated: Jul 09, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry